D-1051-2017 Class II Terminated
FDA drug recall D-1051-2017 was initiated by Bayer HealthCare Pharmaceuticals, Inc. on Mar 30, 2017 and is designated Class II. Reason for recall: Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs. The recall status is terminated (terminated Jan 8, 2020). Affected quantity: 56,064 36-count cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Aug 9, 2017
- Initiation Date
- Mar 30, 2017
- Termination Date
- Jan 8, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 56,064 36-count cartons
Product description
Alka-Seltzer Gold (1000 mg Anhydrous citric acid, 344 mg Antacid Potassium bicarbonate, 1050 mg Antacid Sodium bicarbonate/Antacid) Effervescent Tablets, 36-count carton, Made in Germany, Distributed by Bayer HealthCare, LLC Whippany, NJ 07981, UPC 016500041085
Reason for recall
Defective Container: Confirmed customer compliant of small holes or cracks in the foil of blister packs.
Distribution pattern
Nationwide
Code information
BTAHGR0; Exp. 05/19 BTAHGR1; Exp. 05/19 BTAHGR2; Exp. 05/19 BTAJ0K3; Exp. 07/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1051-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026